FDA Inspection
Baxter Pharmaceuticals India Pvt LtdBaxter Pharmaceuticals India Pvt Ltd – FDA Inspection, Jun 16, 2010
Record Details
This FDA Inspection record concerns Baxter Pharmaceuticals India Pvt Ltd, with an inspection on June 16, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 16, 2010
- Product Type
- Drugs
View Company Profile
ID · b081c5d5-d0d4-4f18-86f5-04724c38d345
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 676775
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Baxter Pharmaceuticals India Pvt Ltd
10| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2025 | Not classified | Office of Inspections and Investigations | |
| January 27, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 4, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Baxter Pharmaceuticals India Pvt Ltd
- FDA Inspection 1280282 - 2025-06-27
- FDA Inspection 1195842 - 2023-01-27
- FDA Inspection 1169631 - 2022-05-17
- FDA Inspection 1028732 - 2017-08-04
- FDA Inspection 1019107 - 2017-05-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.